Rovalpituzumab Vedotin Biosimilar - Research Grade

Human

DLL3

1mg/ml

IgG1

CHO Cells

Q9NYJ7

Room Temp

DLL3 is a Notch-pathway ligand expressed on neuroendocrine tumours and frequently used as an internalising target for payload delivery in oncology research. This research-grade reagent is an unconjugated, non-therapeutic vedotin-format analog directed at human DLL3, offered as a defined tool for antibody-drug conjugate studies and validated for functional assays. It is supplied for research use only, formulated to a low-endotoxin standard suitable for in vivo work, and produced in scalable milligram to gram quantities for high-throughput laboratories. Applications include internalisation and cytotoxicity assays, in vitro screening, in vivo tumour models, and ADC development.

MMAE

25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

Reconstitute with sterile, distilled water to a final concentration of 1 mg/ml. Gently shake to solubilize completely. Do not vortex.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

1 week